Elliot Norry

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 54% 68% 82%
Transactions
21 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Elliot Norry's trades of Adaptimmune Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-17 2025-01-17
PrS Proposed sale
48,404
267.80
US$3,384,799 		48,404 267.80 US$3,384,799
2025-01-17 2025-01-17
S Sale
85,462 -7.7%
163.39
US$242,140 		85,462 -7.7% 163.39 US$242,140
2025-01-15 2025-01-15
PrS Proposed sale
96,572
220.36
US$1,388,656 		96,572 220.36 US$1,388,656
2025-01-15 2025-01-15
S Sale
9,803 -41.6%
0.57
US$5,635 		9,803 -41.6% 0.57 US$5,635
2025-01-15 2025-01-13
PrS Proposed sale
12,392
0.59
US$7,286 		12,392 0.59 US$7,286
2025-01-15 2025-01-13
S Sale
8,124 -41.4%
0.59
US$4,776 		8,124 -41.4% 0.59 US$4,776
2025-01-15 2025-01-13
S Sale
4,268 -42.2%
0.59
US$2,509 		4,268 -42.2% 0.59 US$2,509
2024-01-17 2024-01-17
S Sale
12,967 -40.2%
0.67
US$8,727 		12,967 -40.2% 0.67 US$8,727
2024-01-17 2024-01-17
S Sale
5,309 -40.5%
0.67
US$3,573 		5,309 -40.5% 0.67 US$3,573
2024-01-17 2024-01-16
S Sale
2,287 -40.5%
0.79
US$1,807 		2,287 -40.5% 0.79 US$1,807
2024-01-12 2024-01-12
S Sale
7,799 -39.7%
0.85
US$6,661 		7,799 -39.7% 0.85 US$6,661
2024-01-12 2024-01-11
S Sale
4,009 -39.6%
0.84
US$3,354 		4,009 -39.6% 0.84 US$3,354
2023-01-17 2023-01-17
S Sale
2,159 -38.2%
1.86
US$4,011 		2,159 -38.2% 1.86 US$4,011
2023-01-12 2023-01-12
S Sale
7,449 -37.9%
1.71
US$12,708 		7,449 -37.9% 1.71 US$12,708
2023-01-12 2023-01-11
S Sale
3,843 -38.0%
1.75
US$6,713 		3,843 -38.0% 1.75 US$6,713
2023-01-04 2023-01-04
S Sale
876 -39.2%
1.69
US$1,484 		876 -39.2% 1.69 US$1,484
2022-01-18 2022-01-18
S Sale
2,121 -37.5%
3.19
US$6,770 		2,121 -37.5% 3.19 US$6,770
2022-01-13 2022-01-12
S Sale
854 -38.2%
3.54
US$3,027 		854 -38.2% 3.54 US$3,027
2022-01-13 2022-01-11
S Sale
3,770 -37.3%
3.56
US$13,409 		3,770 -37.3% 3.56 US$13,409
2022-01-05 2022-01-04
S Sale
849 -38.0%
4.06
US$3,451 		849 -38.0% 4.06 US$3,451
2021-01-19 2021-01-19
S Sale
2,111 -37.4%
5.67
US$11,968 		2,111 -37.4% 5.67 US$11,968
2021-01-12 2021-01-12
S Sale
841 -37.6%
6.15
US$5,174 		841 -37.6% 6.15 US$5,174
2021-01-05 2021-01-04
S Sale
845 -37.8%
5.33
US$4,502 		845 -37.8% 5.33 US$4,502
2020-01-15 2020-01-14
S Sale
911 -40.7%
5.13
US$4,678 		911 -40.7% 5.13 US$4,678